Using a Built-in Clinical Decision Support to Improve Phosphate Repletion Practice: A Quasi-Experimental Study

IF 2.3 Q2 HEALTH CARE SCIENCES & SERVICES Joint Commission journal on quality and patient safety Pub Date : 2024-07-31 DOI:10.1016/j.jcjq.2024.07.009
Peter Alarcon Manchego MD (is Director for Pediatric Value, Office of Quality and Safety, NYC Health + Hospitals, New York, and Pediatrician, Kings County Hospital, Brooklyn, New York.), Mona Krouss MD (formerly Assistant Vice President of Value and Patient Safety, NYC Health + Hospitals, is Chief of Hospital Medicine and Director of Inpatient Quality, James J. Peters VA [US Department of Veterans Affairs] Medical Center, Bronx, New York, and Associate Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.), Daniel Alaiev (formerly Director of Outcomes and Biostatistics, NYC Health + Hospitals, is Medical Student, Perelman School of Medicine, University of Pennsylvania.), Joseph Talledo MS (is Data Analyst, Office of Quality and Safety, NYC Health + Hospitals.), Surafel Tsega MD (is Hospitalist, NYC Health + Hospitals/King's County, and Assistant Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai.), Komal Chandra PhD (is Director of Operations for Patient Safety and High Value Care, NYC Health + Hospitals.), Milana Zaurova M (is Director of Quality, Equity, and Palliative Care, Office of Quality and Safety, NYC Health + Hospitals, and Assistant Professor, Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai.), Dawi Shin (is Medical Student, Icahn School of Medicine at Mount Sinai.), Victor Cohen PharmD (is Assistant Vice President, Pharmacy Services, NYC Health + Hospitals.), Hyung J Cho MD (is Internist. and Vice President of Quality, Department of Quality and Safety, Brigham and Women's Hospital, Boston. Please address correspondence to Peter Alacon Manchego)
{"title":"Using a Built-in Clinical Decision Support to Improve Phosphate Repletion Practice: A Quasi-Experimental Study","authors":"Peter Alarcon Manchego MD (is Director for Pediatric Value, Office of Quality and Safety, NYC Health + Hospitals, New York, and Pediatrician, Kings County Hospital, Brooklyn, New York.),&nbsp;Mona Krouss MD (formerly Assistant Vice President of Value and Patient Safety, NYC Health + Hospitals, is Chief of Hospital Medicine and Director of Inpatient Quality, James J. Peters VA [US Department of Veterans Affairs] Medical Center, Bronx, New York, and Associate Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.),&nbsp;Daniel Alaiev (formerly Director of Outcomes and Biostatistics, NYC Health + Hospitals, is Medical Student, Perelman School of Medicine, University of Pennsylvania.),&nbsp;Joseph Talledo MS (is Data Analyst, Office of Quality and Safety, NYC Health + Hospitals.),&nbsp;Surafel Tsega MD (is Hospitalist, NYC Health + Hospitals/King's County, and Assistant Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai.),&nbsp;Komal Chandra PhD (is Director of Operations for Patient Safety and High Value Care, NYC Health + Hospitals.),&nbsp;Milana Zaurova M (is Director of Quality, Equity, and Palliative Care, Office of Quality and Safety, NYC Health + Hospitals, and Assistant Professor, Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai.),&nbsp;Dawi Shin (is Medical Student, Icahn School of Medicine at Mount Sinai.),&nbsp;Victor Cohen PharmD (is Assistant Vice President, Pharmacy Services, NYC Health + Hospitals.),&nbsp;Hyung J Cho MD (is Internist. and Vice President of Quality, Department of Quality and Safety, Brigham and Women's Hospital, Boston. Please address correspondence to Peter Alacon Manchego)","doi":"10.1016/j.jcjq.2024.07.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Inpatient serum phosphate replacement is common, but there is great variability in replacement practice, which leads to overuse. Electronic health record (EHR) interventions with clinical decision support (CDS) can be effective tools to guide clinicians toward best clinical practices. The authors’ objective was to use CDS tools to reduce overuse of hypophosphatemia corrections at a large safety-net health care system.</div></div><div><h3>Methods</h3><div>The first intervention involved enhancing an existing order set for phosphate repletion by incorporating CDS to guide appropriate repletion orders based on deficit severity and simplifying ordering. The second intervention was a Best Practice Advisory (BPA) that triggered when an intravenous (IV) phosphate repletion was ordered for a patient with mild to moderate phosphate deficiency without an existing nil per os (NPO) order. The primary outcome measure was the number of patients with mild and moderate hypophosphatemia receiving IV replacement without NPO orders per 1,000 patient-days.</div></div><div><h3>Results</h3><div>Across all hospitals, rate of IV replacement in patients with mild to moderate hypophosphatemia (1.0 to 1.9 mg/dL) without NPO orders decreased from 7.22 to 3.40 per 1,000 patient-days (53.0% reduction, <em>p</em> &lt; 0.001), while the oral replacements in this population increased from 6.39 to 8.87 (38.8% increase, <em>p</em> &lt; 0.001). For patients with phosphate levels ≥ 2.0, IV replacements decreased from 10.66 to 5.36 (49.8% reduction, <em>p</em> &lt; 0.001), and oral replacements from decreased 19.78 to 16.69 (15.6% reduction, <em>p</em> &lt; 0.01).</div></div><div><h3>Conclusion</h3><div>This intervention successfully reduced inpatient IV phosphate replacements by 53.0% in patients with mild to moderate hypophosphatemia using a two-pronged EHR intervention across a large safety-net setting.</div></div>","PeriodicalId":14835,"journal":{"name":"Joint Commission journal on quality and patient safety","volume":"50 11","pages":"Pages 801-808"},"PeriodicalIF":2.3000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Joint Commission journal on quality and patient safety","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553725024002319","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Inpatient serum phosphate replacement is common, but there is great variability in replacement practice, which leads to overuse. Electronic health record (EHR) interventions with clinical decision support (CDS) can be effective tools to guide clinicians toward best clinical practices. The authors’ objective was to use CDS tools to reduce overuse of hypophosphatemia corrections at a large safety-net health care system.

Methods

The first intervention involved enhancing an existing order set for phosphate repletion by incorporating CDS to guide appropriate repletion orders based on deficit severity and simplifying ordering. The second intervention was a Best Practice Advisory (BPA) that triggered when an intravenous (IV) phosphate repletion was ordered for a patient with mild to moderate phosphate deficiency without an existing nil per os (NPO) order. The primary outcome measure was the number of patients with mild and moderate hypophosphatemia receiving IV replacement without NPO orders per 1,000 patient-days.

Results

Across all hospitals, rate of IV replacement in patients with mild to moderate hypophosphatemia (1.0 to 1.9 mg/dL) without NPO orders decreased from 7.22 to 3.40 per 1,000 patient-days (53.0% reduction, p < 0.001), while the oral replacements in this population increased from 6.39 to 8.87 (38.8% increase, p < 0.001). For patients with phosphate levels ≥ 2.0, IV replacements decreased from 10.66 to 5.36 (49.8% reduction, p < 0.001), and oral replacements from decreased 19.78 to 16.69 (15.6% reduction, p < 0.01).

Conclusion

This intervention successfully reduced inpatient IV phosphate replacements by 53.0% in patients with mild to moderate hypophosphatemia using a two-pronged EHR intervention across a large safety-net setting.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用内置临床决策支持改进磷酸盐补充实践:准实验研究
背景:住院患者血清磷酸盐置换很常见,但置换实践中存在很大差异,导致过度使用。具有临床决策支持(CDS)功能的电子健康记录(EHR)干预是指导临床医生采用最佳临床实践的有效工具。作者的目标是在一个大型安全网医疗保健系统中使用临床决策支持工具来减少低磷血症纠正的过度使用:第一项干预措施是加强现有的磷酸盐补液医嘱集,将 CDS 纳入其中,根据缺失严重程度指导适当的补液医嘱,并简化医嘱。第二项干预措施是在为轻度至中度磷酸盐缺乏的患者开具静脉注射磷酸盐补充剂(IV)的医嘱时触发最佳实践建议(BPA),而该医嘱并没有开具 "无 "磷酸盐(NPO)医嘱。主要结果指标是每 1,000 个患者日中有多少轻度和中度低磷血症患者在没有 NPO 订单的情况下接受了静脉注射磷酸盐补充:在所有医院中,轻度和中度低磷酸盐血症(1.0 至 1.9 mg/dL)患者无 NPO 订单的静脉替代率从每 1,000 个患者日 7.22 例降至 3.40 例(降幅为 53.0%,p < 0.001),而该人群的口服替代率从 6.39 例增至 8.87 例(增幅为 38.8%,p < 0.001)。对于磷酸盐水平≥2.0的患者,静脉替代剂量从10.66降至5.36(减少49.8%,p<0.001),口服替代剂量从19.78降至16.69(减少15.6%,p<0.01):在一个大型安全网环境中,采用双管齐下的电子病历干预措施,成功地将轻度至中度低磷血症患者的住院静脉磷酸盐置换量减少了 53.0%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.80
自引率
4.30%
发文量
116
审稿时长
49 days
期刊最新文献
Table of Contents Editorial Board The Joint Commission Journal on Quality and Patient Safety 50th Anniversary Article Collections: Patient Communication Protecting Parkinson's Patients: Hospital Care Standards to Avoid Preventable Harm Table of Contents
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1